|
|
|
| Join The Advancing RNA Community | Introducing Advancing RNA, an online community designed to be a forum and resource for professionals working on RNA-based therapeutics to better understand the challenges that confront them in areas like analytical/quality, manufacturing, formulation, outsourcing, clinical research, and supply chain/logistics. Sign up for the Advancing RNA newsletter, delivered to your inbox weekly. |
|
|
|
|
Life sciences companies in early stages of clinical development must strike a balance between supporting innovation that drives company valuation and remaining financially prudent. |
|
|
|
Despite the continuation of a poor funding climate in biotech, 2023 was a big year for antibody-drug conjugates. Dive into the details and makeup of the year's ADC market frenzy with Dr. Joe Daccache and Rebecca Bair from DeciBio. |
|
|
|
|
|
| Monoclonals: Revolutionizing Pathogen Treatments | Infectious disease mAb therapies are entering clinical trials at a record pace. Review the trends driving the use of mAb treatments as well as key considerations to remain competitive in the race to market. |
|
|
CONTRIBUTE TO LIFE SCIENCE LEADER |
|
|
|
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director. |
|
|
| Connect With Life Science Leader: |
|
|
|
